Cardiovascular Risk in Digital Osteoarthritis
RICARDI
Assessment of Cardiovascular Risk in Digital Osteoarthritis: A Case-control Study.
1 other identifier
interventional
100
1 country
1
Brief Summary
The goal of this cross-sectional case control study is to investigate the cardiovascular risk in digital osteoarthritis. This study aims to compare the cardiovascular risk between group of patients with digital osteoarthritis and control group of patients with non-osteoarthritis disease paired by measurement of carotid intima-media thickness. All participants will undergo an ultrasound scan to measure carotid intima media thickness, a clinical assessment with the rheumatologist and a cardiovascular risk assessment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 15, 2023
CompletedFirst Posted
Study publicly available on registry
June 28, 2023
CompletedStudy Start
First participant enrolled
October 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 4, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 4, 2026
ExpectedApril 3, 2024
April 1, 2023
2 years
June 15, 2023
April 2, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Measurement of carotid intima-media thickness
EIM is a non-invasive ultrasound technique in which an ultrasound-generating probe is conventionally placed opposite the right primitive carotid artery. By distinguishing between an inner layer, consisting of the intima and media, and the outer layer, the adventitia, the intima-media thickness can be assessed.
20 minutes
Secondary Outcomes (4)
Cardiovascular risk assessment by SCORE scale
10 minutes
Identify endothelial dysfunction in coronary arteries by reactive hyperemia index score
15 minutes
Measurement of bone mineral density and body mass composition by DXA
15 minutes
Physical performance assessment by measuring the distance covered in metres in 6 minutes over a 30-metre course
6 minutes
Study Arms (2)
Case group : digital osteoarthritis
OTHERControl group : lumbago, osteoporosis
OTHERInterventions
EIM is a non-invasive ultrasound technique in which an ultrasound-generating probe is conventionally placed opposite the right primary carotid artery. By distinguishing between an inner layer, consisting of the intima and media, and the outer layer, the adventitia, the intima-media thickness can be assessed.
Performed by the rheumatologist, to quantify the number of synovial thickenings in B mode and the number of synovitis in Doppler mode. The presence or absence of joint erosions on the metacarpophalangeal (MCP), proximal interphalangeal (PPI) or distal interphalangeal (DIP) joints.
It's a measurement that detects endothelial dysfunction in coronary arteries using reactive hyperemia.This examination will be carried out in accordance with the manufacturer's instructions by the Rheumatology Department nurse. The patient lies down for the duration of the examination (20 minutes). A probe is placed on the index finger of each hand and a cuff on the left arm. Recording begins with a 5-minute baseline period (at rest), followed by a 5-minute period of arm occlusion, and ends with a 5-minute period of return to normal.
This X-ray examination will be carried out on the Hologic device and the analyses by APEX 4.0 software. Two-photon X-ray absorptiometry (DXA) is a method commonly used to measure bone mineral density. It is based on a scan of the body by an X-ray beam at 2 different energy levels, which enables 3 compartments to be individualized: mineral mass, lean mass and fat mass. This low-radiation method (less than a conventional chest X-ray) is regarded as a benchmark for accurate measurement of both bone mineral density and the various body compartments. The examination lasts 10 minutes and is carried out by the department's electroradiology manipulators
Eligibility Criteria
You may qualify if:
- For all subjects:
- Adult male or female subject
- Able to give informed consent to participate in research
- Affiliated with a Social Security plan
- For the digital osteoarthritis group:
- Consultant in Rheumatology at Clermont-Ferrand University Hospital
- Affected by digital osteoarthritis meeting ACR diagnostic criteria with radiographic signs of osteoarthritis validated by a radiologist.
- For the control group :
- Rheumatology consultant at the Clermont-Ferrand University Hospital or hospitalized in this department for a non-arthritic, non-rheumatic pathology.
- Patients with spinal disc pathology (lumbago, radiculalgia due to disco-radicular conflict) or non-severe osteoporosis, i.e. with a densitometric T score between -2.5 and -3 DS.
You may not qualify if:
- For all topics :
- Refusal to participate
- Pregnant women, nursing mothers
- Subjects under guardianship or curatorship, deprived of liberty, or under court protection
- For the digital osteoarthritis group:
- For the control group :
- Existence of chronic inflammatory rheumatism (rheumatoid arthritis, spondylitis, psoriatic arthritis, lupus, gout, chondrocalcinosis...)
- Existence of digital osteoarthritis
- Existence of another painful arthritic site (knee, hip, rachi) Existence of finger pain, whatever the etiology.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Clermont Ferrand
Clermont-Ferrand, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sylvain Mathieu
University Hospital, Clermont-Ferrand
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 15, 2023
First Posted
June 28, 2023
Study Start
October 4, 2023
Primary Completion
October 4, 2025
Study Completion (Estimated)
October 4, 2026
Last Updated
April 3, 2024
Record last verified: 2023-04